Valproate Compared With Risperidone for Bipolarity in Young Children
About this title
Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
Read the official source — NCT02456454Researchers compared Risperidone, Valproic Acid and placebo to find out how the approaches affected manic symptoms in children with bipolarity.
Understand this study
What did researchers investigate?
Researchers compared Risperidone, Valproic Acid and placebo to find out how the approaches affected manic symptoms in children with bipolarity.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 3 years to 7 years. Other eligibility criteria applied.
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 46
- Sponsor
- Nationwide Children's Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Not clearly listed
- Age range
- From 3 Years to 7 Years
- Official registry ID
- NCT02456454
- Official title
Show the full official title
Placebo Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Locations not listed
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Risperidone, Valproic Acid and placebo to find out how the approaches affected manic symptoms in children with bipolarity.
Who is behind this study?
The study sponsor is Nationwide Children's Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Risperidone, Valproic Acid and Placebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 3 years to 7 years. Other eligibility criteria applied.
